|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Hugh Sinclair Unit of Human Nutrition, School of Food Biosciences, The University of Reading, Reading, United Kingdom (ST, SK, CMW, and PY), and the Institute of Human Nutrition, University of Southampton, Southampton, United Kingdom (GCB, TB, JJR, RFG, and PCC)
Background: Animal studies have suggested that conjugated linoleic acid (CLA), a natural component of ruminant meat and dairy products, may confer beneficial effects on health. However, little information on the effects of CLA on immune function is available, especially in humans. Furthermore, the effects of individual isomers of CLA have not been adequately investigated.
Objective: This study investigated the effects of supplementing the diet with 3 doses of highly enriched cis-9,trans-11 CLA (0.59, 1.19, and 2.38 g/d) or trans-10,cis-12 CLA (0.63, 1.26, and 2.52 g/d) on immune outcomes in healthy humans.
Design: The study had a randomized, double-blind, crossover design. Healthy men consumed 1, 2, and 4 capsules sequentially that contained 80% of either cis-9,trans-11 CLA or trans-10,cis-12 CLA for consecutive 8-wk periods. This regimen was followed by a 6-wk washout and a crossover to the other isomer.
Results: Both CLA isomers decreased mitogen-induced T lymphocyte activation in a dose-dependent manner. There was a significant negative correlation between mitogen-induced T lymphocyte activation and the proportions of both cis-9,trans-11 CLA and trans-10,cis-12 CLA in peripheral blood mononuclear cell lipids. However, CLA did not affect lymphocyte subpopulations or serum concentrations of C-reactive protein and did not have any consistent effects on ex vivo cytokine production.
Conclusion: CLA supplementation results in a dose-dependent reduction in the mitogen-induced activation of T lymphocytes. The effects of cis-9,trans-11 CLA and trans-10,cis-12 CLA were similar, and there was a negative correlation between mitogen-induced T lymphocyte activation and the cis-9,trans-11 CLA and trans-10,cis-12 CLA contents of mononuclear cells.
Key Words: Conjugated linoleic acid cytokines immunity inflammation lymphocytes
This article has been cited by other articles:
![]() |
C. Ramirez-Santana, C. Castellote, M. Castell, M. Rivero, M. Rodriguez-Palmero, A. Franch, and F. J. Perez-Cano Long-Term Feeding of the cis-9,trans-11 Isomer of Conjugated Linoleic Acid Reinforces the Specific Immune Response in Rats J. Nutr., January 1, 2009; 139(1): 76 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Kelley, N. E. Hubbard, and K. L. Erickson Conjugated Linoleic Acid Isomers and Cancer J. Nutr., December 1, 2007; 137(12): 2599 - 2607. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Coakley, E. Barrett, J. J. Murphy, R. P. Ross, R. Devery, and C. Stanton Cheese Manufacture with Milk with Elevated Conjugated Linoleic Acid Levels Caused by Dietary Manipulation J Dairy Sci, June 1, 2007; 90(6): 2919 - 2927. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Ip, S. O. McGee, P. A. Masso-Welch, C. Ip, X. Meng, L. Ou, and S. F. Shoemaker The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium Carcinogenesis, June 1, 2007; 28(6): 1269 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Calder Immunological Parameters: What Do They Mean? J. Nutr., March 1, 2007; 137(3): 773S - 780S. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Jones, K. J. Shingfield, C. Kohen, A. K. Jones, B. Lupoli, A. S. Grandison, D. E. Beever, C. M. Williams, P. C. Calder, and P. Yaqoob Chemical, Physical, and Sensory Properties of Dairy Products Enriched with Conjugated Linoleic Acid J Dairy Sci, August 1, 2005; 88(8): 2923 - 2937. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |